Lung Cancer Trial, By Invitation NCT06324110 Sponsor: Fred Hutchinson Cancer Center Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, By Invitation

NCT06324110
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • (AIM II – Screening Data): People aged 50 to 80 years old.
  • (AIM II – Screening Data): People who currently smoke or who quit smoking within the last 15 years.
  • (AIM II – Screening Data): People who have smoked at least 20 pack-years (roughly one pack per day for 20 years, or an equivalent amount over more or fewer years).
  • (AIM II – Screening Data): People who have had at least one low-dose CT chest scan for lung cancer screening at a partnering site during the study period.
  • (AIM III – Healthcare Provider Interviews): People aged 18 or older.
  • (AIM III – Healthcare Provider Interviews): People who work with Skagit Regional Health System, Confluence Health, or Kadlec Regional Medical Center.
  • (AIM III – Healthcare Provider Interviews): People who identify as providing primary or specialty care to lung cancer screening patients, in the role of medical doctor (MD), registered nurse (RN), physician assistant (PA), or advanced registered nurse practitioner (ARNP).
  • (AIM III – Patient Interviews): People aged 50 to 80 years old.
  • (AIM III – Patient Interviews): People who received lung cancer screening at Skagit Regional Health System, Confluence Health, or Kadlec Regional Medical Center during the intervention period.
  • (AIM III – Patient Interviews): People who met the U.S. Preventive Services Task Force (USPSTF) guidelines for lung cancer screening at the time their screening was done.
  • (General): People aged 50 to 80 at the time of their scan.
  • (General): People with at least a 20 pack-year smoking history.
  • (General): People who currently smoke or who stopped smoking within the last 15 years.
  • (AIM III – Lung Cancer Screening Care Coordinators): People aged 18 or older.
  • (AIM III – Lung Cancer Screening Care Coordinators): People who work with Skagit Regional Health System, Confluence Health, or Kadlec Regional Medical Center.
  • (AIM III – Lung Cancer Screening Care Coordinators): People who identify as playing a supportive role in the lung cancer screening care process as part of the study's centralising program.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • (AIM II – Screening Data): People who are no longer eligible for lung cancer screening CT scans during the follow-up period because they no longer meet the inclusion criteria.
  • (AIM II – Screening Data): People who request not to participate in the trial.
  • (AIM III – Healthcare Provider Interviews): People under the age of 18.
  • (AIM III – Healthcare Provider Interviews): People who do not have an affiliation with Skagit Regional Health System, Confluence Health, or Kadlec Regional Medical Center.
  • (AIM III – Healthcare Provider Interviews): People who do not identify as providing primary or specialty care to lung cancer screening patients as an MD, RN, PA, or ARNP.
  • (AIM III – Patient Interviews): People younger than 50 or older than 80.
  • (AIM III – Patient Interviews): People who did not receive lung cancer screening at Skagit Regional Health System, Confluence Health, or Kadlec Regional Medical Center during the intervention period.
  • (AIM III – Patient Interviews): People who did not meet the USPSTF criteria for lung cancer screening at the time their screening was performed.
  • (AIM III – Lung Cancer Screening Care Coordinators): People under the age of 18.
  • (AIM III – Lung Cancer Screening Care Coordinators): People who do not have an affiliation with Skagit Regional Health System, Confluence Health, or Kadlec Regional Medical Center.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 17 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
31 October 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Adherence to appropriate follow-up

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 17 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov